New decontamination protocol permits reuse of N95 respirators
The COVID-19 pandemic has created a shortage of personal protective equipment, including "N95" face respirators, needed by frontline healthcare providers. A new protocol using aerosolized hydrogen peroxide to decontaminate N95 respirators could allow them to be safely reused in some hospital settings, where the disinfectant is already being used for other decontamination purposes. The protocol, optimized by a team of Penn State researchers, inactivates viruses with no indication that the respirator is deformed or damaged over ten decontamination cycles, as reflected by rigorous respirator fit-testing.
Respirators, a type of mask designed to seal tightly to the wearer's face, are frequently used to provide protection from airborne infectious particles like viruses. Unlike other hospital equipment that have established decontamination protocols, N95 respirators were not intended for reuse. However, the current COVID-19 pandemic has led to a shortage of N95 respirators, resulting from limitations in both manufacturing and supply chains due to increased demands.
"Vapor-phase and aerosolized hydrogen peroxide is routinely used in containment laboratories to decontaminate sensitive equipment and large, pre-cleaned spaces," said Melissa James, facility manager for the Eva J. Pell ABSL3 Laboratory for Advanced Biological Research at Penn State. "Many facilities use high concentrations (35%) of hydrogen peroxide in these processes, however newer technology allows a relatively low concentration (7%) to achieve the same high level of decontamination. We investigated expanding the use of this technology to decontaminate N95 respirators, which are typically used once and discarded."
The research team optimized a protocol for the decontamination process, in which respirators are placed in an air-tight room. The room is filled with aerosolized hydrogen peroxide, which is absorbed into the multiple layers of the respirators, then after a "dwell" period, the ventilation is re-started to safely clear the room of hydrogen peroxide vapors. The respirators are either allowed to dry in place or moved to a separate room with ventilation to expedite drying and for residual hydrogen peroxide to completely decompose into water vapor and oxygen. This decomposition is an essential part of the process, because hydrogen peroxide vapor is irritating and can damage human lung cells.
The researchers inoculated five common models of N95 respirators with three types of virus: herpes simplex virus 1 (HSV-1), coxsackie virus B3 (CVB3), and the Pseduomonas phi6 bacteriophage. Ongoing work on this project will utilize influenza virus and the SARS-CoV-2 pathogen itself.
"We chose these viruses in part because we could test a highly concentrated sample of each within a biosafety level 2 facility," said Moriah Szpara, associate professor of biology and of biochemistry and molecular biology at Penn State. "Hydrogen peroxide treatment demonstrated highly effective decontamination of these viruses. While we plan to do a confirmation study with SARS-CoV-2 in the future, we will need to transition into a biosafety level 3 facility in order to work with it at the high concentrations used for the other human-infecting viruses in this study."
The researchers found that all of the tested viruses within the respirators were destroyed by aerosolized hydrogen peroxide decontamination, indicating that their protocol is effective. The decontamination protocol also destroyed highly-resistant Geobacillus stearothermophilus spores in an easy-to-use commercial test, which is commonly used in laboratories and hospitals to confirm sterilization. This suggests that these spore tests are a good indicator of successful aerosolized hydrogen peroxide respirator decontamination in hospital settings, where full viral studies are often not feasible.
"The viruses we studied represent a range of human viral pathogens, with different types and sizes, genome types and lengths, and environmental stability," said Szpara. "Each shares one or more common characteristic with SARS-CoV-2, which allowed us to test the decontamination potential of aerosolized hydrogen peroxide against a range of pathogens and against the characteristics of SARS-CoV-2."
Successful decontamination techniques for masks must also preserve their structural integrity, without impairing the respirator-to-face seal. To challenge the structural qualities of the respirators, the research team performed rigorous fit testing and simulated conditions of reuse by flexing respirators and stretching elastic between decontamination cycles and fit-test rounds. They found that the aerosolized hydrogen peroxide decontamination procedure did not impact the fit of N95 respirators after one, five, or ten rounds of decontamination.
"To ensure that respirators were effectively challenged between decontamination cycles, we performed both qualitative and quantitative fit testing following the Occupational Safety and Health Administration (OSHA) protocols," said Hans Derr, manager of health and environmental programs at the Penn State's Office of Physical Plant, Department of Environmental Health and Safety. "Each fit test involves a number of exercises to challenge fit and to indicate or measure potential leakage. Adequate numbers of fit tests were performed to ensure high levels of confidence and reliability in testing."
The researchers reported their initial results in a paper appearing today (April 22) on the pre-print server, medRxiv. Next, they plan to extend their testing through 15 decontamination cycles, to perform additional viral decontamination tests using influenza and SARS-CoV-2, and to conduct separate respirator filtration efficiency tests, to further validate respirator integrity following decontamination.
"Hospitals and clinical facilities could choose to implement this N95 decontamination protocol during the COVID-19 pandemic to help overcome shortages of vital personal protective equipment, and integrate it into their emergency preparedness plan to help prevent these types of problems from recurring," said Szpara. "We conducted this research as part of the broader Penn State MASC initiative, and our team and MASC leadership have been communicating with hospitals in central Pennsylvania about this and other potential decontamination protocols since the onset of COVID-19 in the state. We hope that this work can make a difference at hospitals, both locally and worldwide."